Michelle Yanez

Michelle Yanez

Directeur/Membre du Conseil chez HEDGEPATH PHARMACEUTICALS INC

Fortune : 108 693 $ au 31/08/2026

54 ans
Health Technology
Consumer Services
Commercial Services

Profil

Ms. Michelle Yanez is an Independent Director at Inhibitor Therapeutics, Inc., a Member at Institute of Management Accountants, Inc. and a Member at Sec Professionals Group.
She is on the Board of Directors at Inhibitor Therapeutics, Inc. Ms. Yanez was previously employed as a Chief Financial Officer, Secretary & Treasurer by MIRA Pharmaceuticals, Inc., a Chief Financial Officer, Secretary & Treasurer by Telomir Pharmaceuticals, Inc., and a Director-Financial Reporting by BioDelivery Sciences International, Inc. She received her undergraduate degree from the University of South Florida and an MBA from Rutgers Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/08/2026 1 221 271 ( 0,7 % ) 108 693 $ 31/08/2026

Postes actifs de Michelle Yanez

SociétésPosteDébut
HEDGEPATH PHARMACEUTICALS INC Directeur/Membre du Conseil 13/10/2023
Corporate Officer/Principal -
Corporate Officer/Principal -

Anciens postes connus de Michelle Yanez

SociétésPosteFin
MIRA PHARMACEUTICALS, INC. Directeur Financier/CFO 16/05/2025
TELOMIR PHARMACEUTICALS, INC. Directeur Financier/CFO 15/05/2025
HEDGEPATH PHARMACEUTICALS INC Directeur/Membre du Conseil 14/05/2023
BIODELIVERY SCIENCES INTERNATIONAL, INC. Corporate Officer/Principal 01/04/2022
Voir l'expérience en détail de Michelle Yanez

Formation de Michelle Yanez

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

47

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Consumer Services

Commercial Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Michelle Yanez
🔇